Molecular evidence of engraftment in bone marrow after nonmyeloablative allogeneic stem cell transplant (NMASCT) is an unreliable indicator of residual/recurrent disease in the marrow.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lagoo, AS; Gong, JZ; Rizzieri, DA; Stenzel, TT; Chao, NJ; Buckley, PJ

Published Date

  • November 16, 2001

Published In

Volume / Issue

  • 98 / 11

Start / End Page

  • 185A - 185A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • English